BBHC
ANGO icon

Brown Brothers Harriman & Co’s AngioDynamics ANGO Stock Holding History

Brown Brothers Harriman & Co’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.89K Hold
299
– – ﹤0.01% 1623
2026
Q1 		$3.4K Sell
299
-36
-11% -$390 ﹤0.01% 1599
2025
Q4 		$4.3K Buy
+335
New +$4.13K ﹤0.01% 1552

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown Brothers Harriman & Co's ANGO Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its AngioDynamics (ANGO) position steady in Q2 2026 at 299 shares worth $3.89K. The position accounts for ﹤0.01% of the portfolio, ranked #1623.

Brown Brothers Harriman & Co first reported a position in ANGO in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.3K in Q4 2025. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Brown Brothers Harriman & Co held 299 shares of AngioDynamics worth $3.89K as of Q2 2026.
  • Brown Brothers Harriman & Co left its AngioDynamics share count unchanged in Q2 2026.
  • AngioDynamics made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1623 holding.
  • Brown Brothers Harriman & Co first reported a position in AngioDynamics in Q4 2025 and has held it in 3 quarters since.
  • Brown Brothers Harriman & Co's AngioDynamics position peaked at $4.3K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.